Association Between Admission Serum Phosphate Level and All-Cause Mortality Among Patients with Spontaneous Intracerebral Hemorrhage

References

• Alerhand S, Lay C. Spontaneous intracerebral hemorrhage. Emerg Med Clin North Am. 2017;35(4):825–845. doi:10.1016/j.emc.2017.07.002
   PubMed Web of Science ®Google Scholar
• Josephson CB, Frantzias J, Samarasekera N, Al-Shahi Salman R. The persisting burden of intracerebral haemorrhage: can effective treatments be found? PLoS Med. 2010;7(10):e1000353. doi:10.1371/journal.pmed.1000353
   Web of Science ®Google Scholar
• Fewel ME, Thompson BG Jr, Hoff JT. Spontaneous intracerebral hemorrhage: a review. Neurosurg Focus. 2003;15(4):E1. doi:10.3171/foc.2003.15.4.0
   Google Scholar
• Al-Shahi Salman R, Labovitz DL, Stapf C. Spontaneous intracerebral haemorrhage. BMJ. 2009;339:b2586. doi:10.1136/bmj.b2586
   Web of Science ®Google Scholar
• Bai Q, Sheng Z, Liu Y, Zhang R, Yong VW, Xue M. Intracerebral haemorrhage: from clinical settings to animal models. Stroke Vasc Neurol. 2020;5(4):388–395.
   Google Scholar
• Rincon F, Mayer SA. Intracerebral hemorrhage: getting ready for effective treatments. Curr Opin Neurol. 2010;23(1):59–64. doi:10.1097/WCO.0b013e3283352c01
   Web of Science ®Google Scholar
• Hostettler IC, Seiffge DJ, Werring DJ. Intracerebral hemorrhage: an update on diagnosis and treatment. Expert Rev Neurother. 2019;19(7):679–694. doi:10.1080/14737175.2019.1623671
   PubMed Web of Science ®Google Scholar
• Veltkamp R, Purrucker J. Management of spontaneous intracerebral hemorrhage. Curr Neurol Neurosci Rep. 2017;17(10):80. doi:10.1007/s11910-017-0783-5
   PubMed Web of Science ®Google Scholar
• Moulin S, Cordonnier C. Prognosis and outcome of intracerebral haemorrhage. Front Neurol Neurosci. 2015;37:182–192.
   Google Scholar
• Gutiérrez OM. Increased serum phosphate and adverse clinical outcomes: unraveling mechanisms of disease. Curr Opin Nephrol Hypertens. 2011;20(3):224–228. doi:10.1097/MNH.0b013e328343ea70
   PubMed Web of Science ®Google Scholar
• Lederer E. Why would serum phosphorus correlate with cardiovascular risk, and how is the clinician supposed to use this information? Clin Nephrol. 2017;87(1):1–10. doi:10.5414/CN108916
   Web of Science ®Google Scholar
• Padelli M, Leven C, Sakka M, Plée-Gautier E, Carré JL. Causes, consequences and treatment of hypophosphatemia: a systematic review. Presse Med. 2017;46(11):987–999. doi:10.1016/j.lpm.2017.09.002
   PubMed Web of Science ®Google Scholar
• Park W, Kim BS, Lee JE, et al. Serum phosphate levels and the risk of cardiovascular disease and metabolic syndrome: a double-edged sword. Diabetes Res Clin Pract. 2009;83(1):119–125. doi:10.1016/j.diabres.2008.08.018
   PubMed Web of Science ®Google Scholar
• Demirjian S, Teo BW, Guzman JA, et al. Hypophosphatemia during continuous hemodialysis is associated with prolonged respiratory failure in patients with acute kidney injury. Nephrol Dial Transplant. 2011;26(11):3508–3514. doi:10.1093/ndt/gfr075
   Web of Science ®Google Scholar
• Otero TMN, Canales C, Yeh DD, et al. Association of serum phosphate levels and anemia in critically ill surgical patients. JPEN J Parenter Enteral Nutr. 2017;41(6):986–992. doi:10.1177/0148607115626415
   Web of Science ®Google Scholar
• Yamada S, Tsuruya K, Taniguchi M, et al. Association between serum phosphate levels and stroke risk in patients undergoing hemodialysis: the Q-cohort study. Stroke. 2016;47(9):2189–2196. doi:10.1161/STROKEAHA.116.013195
   PubMed Web of Science ®Google Scholar
• Junttila E, Koskenkari J, Ala-Kokko T. Hypophosphatemia after nontraumatic intracranial hemorrhage. Acta Anaesthesiol Scand. 2017;61(6):641–649. doi:10.1111/aas.12903
   Web of Science ®Google Scholar
• You S, Han Q, Xu J, et al. Serum calcium and phosphate levels and short- and long-term outcomes in acute intracerebral hemorrhage patients. J Stroke Cerebrovasc Dis. 2016;25(4):914–920. doi:10.1016/j.jstrokecerebrovasdis.2015.12.023
   Web of Science ®Google Scholar
• Divani AA, Majidi S, Luo X, et al. The ABCs of accurate volumetric measurement of cerebral hematoma. Stroke. 2011;42(6):1569–1574. doi:10.1161/STROKEAHA.110.607861
   PubMed Web of Science ®Google Scholar
• Kwah LK, Diong J. National Institutes of Health Stroke Scale (NIHSS). J Physiother. 2014;60(1):61. doi:10.1016/j.jphys.2013.12.012
   PubMed Web of Science ®Google Scholar
• Torres RB, Giovanni Terzi RG, Eriras Falcão AL, Höehr NF, Dantas Filho VP. Hypophosphatemia in severe traumatic brain injury. Rev Bras Terap Intens. 2005;17:116–120.
   Google Scholar
• Faul M, Coronado V. Epidemiology of traumatic brain injury. Handb Clin Neurol. 2015;127:3–13.
   PubMedGoogle Scholar
• Polderman K, Bloemers F, Peerdeman S, Girbes A. Hypomagnesemia and hypophosphatemia at admission in patients with severe head injury. Crit Care Med. 2000;28(6):2022–2025. doi:10.1097/00003246-200006000-00057
   PubMed Web of Science ®Google Scholar
• Polderman KH, Peerdeman SM, Girbes AR. Hypophosphatemia and hypomagnesemia induced by cooling in patients with severe head injury. J Neurosurg. 2001;94(5):697–705. doi:10.3171/jns.2001.94.5.0697
   Web of Science ®Google Scholar
• García Martín A, Varsavsky M, Cortés Berdonces M, et al. Phosphate disorders and clinical management of hypophosphatemia and hyperphosphatemia. Endocrinol Diabetes Nutr. 2020;67(3):205–215. doi:10.1016/j.endinu.2019.06.004
   Web of Science ®Google Scholar
• Zhang D, Zhuang Z, Wei Y, et al. Association of admission serum glucose-phosphate ratio with severity and prognosis of aneurysmal subarachnoid hemorrhage. World Neurosurg. 2019;127:e1145–e1151. doi:10.1016/j.wneu.2019.04.071
   Web of Science ®Google Scholar
• Qiu SZ, Zheng GR, Chen B, Huang JJ, Shen J, Mao W. Prognostic value of admission serum glucose-phosphate ratio in predicting the 6-month outcome of patients with severe traumatic brain injury: a retrospective study. Clin Chim Acta. 2020;510:659–664. doi:10.1016/j.cca.2020.08.038
   Web of Science ®Google Scholar
• Shoji T, Masakane I, Watanabe Y, Iseki K, Tsubakihara Y. Elevated non-high-density lipoprotein cholesterol (non-HDL-C) predicts atherosclerotic cardiovascular events in hemodialysis patients. CJASN. 2011;6(5):1112–1120. doi:10.2215/CJN.09961110
   Web of Science ®Google Scholar
• Kalantar-Zadeh K, Kuwae N, Regidor DL, et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int. 2006;70(4):771–780. doi:10.1038/sj.ki.5001514
   PubMed Web of Science ®Google Scholar
• Larsen VH, Waldau T, Gravesen H, Siggaard-Andersen O. Erythrocyte 2,3-diphosphoglycerate depletion associated with hypophosphatemia detected by routine arterial blood gas analysis. Scand J Clin Lab Invest Suppl. 1996;224:83–87. doi:10.3109/00365519609088626
   Google Scholar
• Ventura-Clapier R, Moulin M, Piquereau J, et al. Mitochondria: a central target for sex differences in pathologies. Clin Sci (Lond). 2017;131(9):803–822. doi:10.1136/svn-2020-000334
   PubMed Web of Science ®Google Scholar
• Johnson MA, Tekkanat K, Schmaltz SP, Fox IH. Adenosine triphosphate turnover in humans. Decreased degradation during relative hyperphosphatemia. J Clin Invest. 1989;84(3):990–995. doi:10.1172/JCI114263
   Web of Science ®Google Scholar
• Haglin L. Using phosphate supplementation to reverse hypophosphatemia and phosphate depletion in neurological disease and disturbance. Nutr Neurosci. 2016;19(5):213–223. doi:10.1179/1476830515Y.0000000024
   PubMed Web of Science ®Google Scholar
• Noda H, Iso H, Irie F, et al. Low-density lipoprotein cholesterol concentrations and death due to intraparenchymal hemorrhage The Ibaraki Prefectural Health Study. Circulation. 2009;119(16):2136–2145. doi:10.1161/CIRCULATIONAHA.108.795666
   Web of Science ®Google Scholar